Reactive Oxygen Species-Responsive Polyether Micelle Nanomaterials for Targeted Treatment of Ulcerative Colitis. 2022

Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.

As one of the most challenging inflammatory diseases, the incidence of ulcerative colitis (UC) is increasing year by year, but the existing therapeutic drugs are not effective and lack of targeting. Nanomaterials are expected to become promising delivery system due to their good targeting effects. Here, we designed a nanomaterial sensitive to reactive oxygen species, which can be used to treat IBD, especially UC. It is a self-assembled polyether micelle that can be oxidized at the inflammation site where the concentration of reactive oxygen increases, and effectively release the encapsulated budesonide (Bud). Experiments have proved that for DSS-induced colitis, the synthetic drug-loaded nanoparticles have excellent therapeutic effects, can effectively repair intestinal barrier, and significantly improve the damaged colon tissue. At the same time, it has a beneficial regulatory effect on inflammatory factors. Molecular mechanism studies have shown that it achieves its therapeutic effects by activating the peroxisome proliferators-activated receptors-γ (PPAR-γ) pathway and inhibiting the nuclear factor (NF)-κB pathway. This study proves that oral nano-micelles have an important impact on improving the efficacy of UC treatment drugs and have far-reaching significance for the targeted treatment of gastrointestinal diseases.

UI MeSH Term Description Entries
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016264 Dextran Sulfate Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4-POSITIVE T-LYMPHOCYTES. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications. Sodium Dextran Sulfate,Dextran Sulfate Sodium,Dextran Sulfate, Sodium,Sulfate Sodium, Dextran,Sulfate, Dextran,Sulfate, Sodium Dextran
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D049329 Nanostructures Materials which have structured components with at least one dimension in the range of 1 to 100 nanometers. These include NANOCOMPOSITES; NANOPARTICLES; NANOTUBES; and NANOWIRES. Nanomaterials,Nanostructured Materials,Material, Nanostructured,Materials, Nanostructured,Nanomaterial,Nanostructure,Nanostructured Material

Related Publications

Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
September 2025, ACS applied materials & interfaces,
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
July 2025, Materials horizons,
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
July 2022, Journal of drug targeting,
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
July 2022, Acta biomaterialia,
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
October 2023, Small (Weinheim an der Bergstrasse, Germany),
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
February 2021, Advanced science (Weinheim, Baden-Wurttemberg, Germany),
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
June 2021, Materials today. Bio,
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
January 2021, Frontiers in chemistry,
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
February 2018, Journal of materials chemistry. B,
Xin-Xin Zhao, and Shan-Bo Ma, and Jin-Peng Wen, and Da-Tao Hu, and Ju-Shan Gao, and Qiao Peng, and Yu-Chen Zhang, and Jin-Qing Wang, and Ke Wang, and Xiao-Peng Shi
July 2016, Journal of materials chemistry. B,
Copied contents to your clipboard!